Vanguard Group’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$944K Sell
178,040
-56,325
-24% -$299K ﹤0.01% 3758
2025
Q1
$1.82M Sell
234,365
-714
-0.3% -$5.53K ﹤0.01% 3519
2024
Q4
$3.11M Sell
235,079
-215
-0.1% -$2.85K ﹤0.01% 3436
2024
Q3
$2.35M Sell
235,294
-115
-0% -$1.15K ﹤0.01% 3507
2024
Q2
$5.25M Sell
235,409
-22,068
-9% -$492K ﹤0.01% 3237
2024
Q1
$15.1M Sell
257,477
-24,289
-9% -$1.43M ﹤0.01% 2729
2023
Q4
$6.24M Sell
281,766
-80,672
-22% -$1.79M ﹤0.01% 3196
2023
Q3
$7.82M Sell
362,438
-27,160
-7% -$586K ﹤0.01% 3026
2023
Q2
$26.3M Buy
389,598
+36,373
+10% +$2.46M ﹤0.01% 2475
2023
Q1
$165M Sell
353,225
-24,538
-6% -$11.4M ﹤0.01% 1558
2022
Q4
$151M Sell
377,763
-11,875
-3% -$4.76M ﹤0.01% 1588
2022
Q3
$127M Buy
389,638
+2,763
+0.7% +$899K ﹤0.01% 1653
2022
Q2
$102M Buy
386,875
+12,877
+3% +$3.4M ﹤0.01% 1815
2022
Q1
$112M Buy
373,998
+12,550
+3% +$3.77M ﹤0.01% 1876
2021
Q4
$127M Buy
361,448
+28,250
+8% +$9.96M ﹤0.01% 1850
2021
Q3
$85.1M Buy
333,198
+17,444
+6% +$4.46M ﹤0.01% 2074
2021
Q2
$210M Buy
315,754
+4,040
+1% +$2.69M 0.01% 1603
2021
Q1
$270M Buy
311,714
+9,116
+3% +$7.91M 0.01% 1403
2020
Q4
$281M Buy
302,598
+7,833
+3% +$7.26M 0.01% 1250
2020
Q3
$303M Sell
294,765
-7,155
-2% -$7.36M 0.01% 1011
2020
Q2
$306M Buy
301,920
+16,762
+6% +$17M 0.01% 1013
2020
Q1
$248M Buy
285,158
+4,021
+1% +$3.49M 0.01% 1009
2019
Q4
$301M Sell
281,137
-10,615
-4% -$11.4M 0.01% 1122
2019
Q3
$270M Buy
291,752
+667
+0.2% +$617K 0.01% 1155
2019
Q2
$329M Buy
291,085
+2,255
+0.8% +$2.55M 0.01% 1046
2019
Q1
$392M Buy
288,830
+3,169
+1% +$4.31M 0.02% 911
2018
Q4
$331M Buy
285,661
+8,786
+3% +$10.2M 0.01% 921
2018
Q3
$421M Buy
276,875
+5,007
+2% +$7.6M 0.02% 887
2018
Q2
$425M Buy
271,868
+12,417
+5% +$19.4M 0.02% 858
2018
Q1
$300M Buy
259,451
+15,348
+6% +$17.7M 0.01% 1030
2017
Q4
$289M Sell
244,103
-9,969
-4% -$11.8M 0.01% 1046
2017
Q3
$342M Buy
254,072
+21,734
+9% +$29.2M 0.02% 930
2017
Q2
$188M Buy
232,338
+30,457
+15% +$24.6M 0.01% 1268
2017
Q1
$124M Buy
201,881
+15,711
+8% +$9.68M 0.01% 1534
2016
Q4
$99.6M Buy
186,170
+5,656
+3% +$3.03M 0.01% 1615
2016
Q3
$93.4M Buy
180,514
+11,706
+7% +$6.06M 0.01% 1603
2016
Q2
$69.3M Buy
168,808
+13,589
+9% +$5.57M ﹤0.01% 1740
2016
Q1
$82.6M Buy
155,219
+11,744
+8% +$6.25M 0.01% 1603
2015
Q4
$109M Buy
143,475
+6,470
+5% +$4.93M 0.01% 1403
2015
Q3
$75.1M Buy
137,005
+38,296
+39% +$21M 0.01% 1631
2015
Q2
$58M Buy
98,709
+79,517
+414% +$46.7M ﹤0.01% 1854
2015
Q1
$15.1M Buy
19,192
+18,593
+3,104% +$14.6M ﹤0.01% 2449
2014
Q4
$409K Buy
+599
New +$409K ﹤0.01% 3787